BMJ Open Gastroenterology
Scope & Guideline
Fostering Collaboration for Transformative Gastrointestinal Care
Introduction
Aims and Scopes
- Inflammatory Bowel Disease (IBD) Research:
Significant focus on the epidemiology, treatment, and management of IBD, including Crohn's disease and ulcerative colitis. This area includes studies on patient experiences, treatment outcomes, and the impact of therapies on quality of life. - Gastrointestinal Oncology:
Research related to the diagnosis, treatment, and outcomes of gastrointestinal cancers, particularly colorectal cancer. This includes studies on risk factors, screening practices, and innovative treatment approaches. - Liver Disease and Hepatology:
Exploration of various liver conditions including non-alcoholic fatty liver disease (NAFLD), hepatitis, and liver cancer. The journal emphasizes the relationship between liver health and systemic conditions, alongside management strategies. - Gastrointestinal Microbiome:
Investigations into the gut microbiota's role in health and disease, including its impact on inflammation and metabolic disorders. This area includes studies on microbiome profiling and therapeutic implications. - Endoscopic Techniques and Innovations:
Focus on advancements in endoscopic procedures and technologies, including their application in diagnosis and treatment of gastrointestinal diseases. Research includes evaluation of new tools and techniques for enhancing patient care. - Patient-Centered Research:
Emphasis on understanding patient experiences, preferences, and outcomes in the management of gastrointestinal diseases. This includes qualitative studies and surveys that inform healthcare practices.
Trending and Emerging
- Artificial Intelligence in Gastroenterology:
There is a growing trend towards incorporating artificial intelligence in diagnostic and therapeutic processes within gastroenterology. This includes studies on AI-assisted endoscopy and predictive algorithms for patient outcomes. - Health Disparities and Social Determinants of Health:
Research addressing the impact of social factors on gastrointestinal health outcomes is on the rise. Studies are increasingly focusing on health disparities in various populations and how these affect disease prevalence and management. - Digital Health and Telemedicine:
With the rise of digital health tools, there is a marked increase in studies exploring the effectiveness of remote monitoring, telehealth consultations, and mobile health applications in managing gastrointestinal diseases. - Microbiome-Related Therapies:
Emerging interest in the therapeutic potential of microbiome modulation, including fecal microbiota transplantation and probiotics, is becoming a significant area of research as understanding of gut microbiota expands. - Longitudinal and Cohort Studies:
There is a trend towards conducting long-term cohort studies that track patient outcomes over time, particularly in chronic conditions like IBD, to better understand disease progression and treatment efficacy.
Declining or Waning
- Traditional Pharmacological Treatments:
There appears to be a decline in studies focused solely on traditional pharmacological approaches to managing gastrointestinal diseases, as newer, more integrative treatment modalities and personalized medicine approaches gain traction. - Basic Science Research:
Research that focuses on the fundamental biological mechanisms underlying gastrointestinal diseases has become less frequent, as there is a notable shift towards applied clinical research and patient outcomes. - Surgical Techniques:
While still important, the frequency of publications centered on traditional surgical techniques in gastroenterology seems to be declining in favor of less invasive approaches and endoscopic innovations.
Similar Journals
Translational Gastroenterology and Hepatology
Connecting Research to Real-World Solutions in Hepatology.Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.
Clinical Gastroenterology and Hepatology
Pioneering Research for Tomorrow's Gastroenterological SolutionsClinical Gastroenterology and Hepatology, published by Elsevier Science Inc, stands as a leading journal in the fields of gastroenterology and hepatology. With an ISSN of 1542-3565 and an E-ISSN of 1542-7714, this esteemed publication has earned its place in the top quartile (Q1) of both gastroenterology and hepatology categories as of 2023, ranking 6th out of 167 and 7th out of 82 respectively. The journal aims to disseminate innovative research, clinical studies, and case reports that advance the understanding and treatment of gastrointestinal and liver diseases. Targeted towards researchers, healthcare professionals, and students, it provides crucial insights into emerging therapies and medical advancements. Clinical Gastroenterology and Hepatology is not only a pivotal resource for contemporary gastroenterological research but also fosters collaboration and knowledge-sharing within the medical community. With a converging publication history from 2003 to the present, the journal continues to build on its solid foundation of scientific excellence and relevance.
United European Gastroenterology Journal
Empowering research for better patient outcomes.The United European Gastroenterology Journal, published by John Wiley & Sons Ltd, is a leading publication in the fields of gastroenterology and oncology, boasting a distinguished Q1 ranking in both categories for 2023. With an ISSN of 2050-6406 and an E-ISSN of 2050-6414, this journal serves as a vital platform for disseminating cutting-edge research and innovative practices from 2013 to 2024, supporting the advancement of knowledge in gastrointestinal health and cancer treatment. With a commendable Scopus Rank of 14th out of 167 in gastroenterology and 54th out of 404 in oncology, it emphasizes the significance of impactful research in these critical areas. While currently not an open-access journal, it remains a vital resource for researchers, professionals, and students seeking comprehensive insights and evidence-based approaches to improve patient care and clinical outcomes. The United European Gastroenterology Journal is committed to bridging the gap between research and practice, making it an essential reference for those dedicated to the fields of gastroenterology and oncology.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Innovative insights into digestive and liver health.Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Pioneering Research for Enhanced Patient OutcomesSCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, published by Taylor & Francis Ltd, is a leading journal in the field of gastroenterology, dedicated to advancing clinical and experimental research related to digestive health. With an ISSN of 0036-5521 and an E-ISSN of 1502-7708, this journal provides a platform for high-quality research that addresses the complexities of gastrointestinal diseases. Since its inception in 1966, the journal has consistently contributed valuable insights and is currently categorized in the Q2 quartile of gastroenterology journals, reflecting its impact and relevance in the field, with a Scopus rank of 87 out of 167 in Medicine - Gastroenterology. Researchers and practitioners are encouraged to explore the journal's archives to enhance their understanding and stay abreast of innovative strategies for managing gastrointestinal disorders. The SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY remains a crucial resource for those committed to improving patient outcomes through rigorous scientific inquiry and the sharing of impactful findings.
Canadian Journal of Gastroenterology and Hepatology
Unveiling the Latest in Gastrointestinal and Liver ScienceCanadian Journal of Gastroenterology and Hepatology, published by HINDAWI LTD, serves as a vital resource in the fields of gastroenterology and hepatology. Since its inception in 1987, this open-access journal has made significant contributions to advancing research and clinical practice through its comprehensive coverage of topics ranging from liver diseases to gastrointestinal disorders. With an impressive Q2 ranking in Gastroenterology and a Q3 ranking in Hepatology as of 2023, the journal has established itself as an influential platform for researchers and healthcare professionals seeking to disseminate and acquire knowledge. The journal is based in Egypt, with its operational headquarters located in London, England. Notably, it holds a respectable standing in Scopus rankings, placed at Rank #64 in Gastroenterology and Rank #34 in Hepatology, reflecting its impact and relevance in the medical community. With a commitment to quality and accessibility, the Canadian Journal of Gastroenterology and Hepatology continues to foster innovation and collaboration among its readers.
Advances in Digestive Medicine
Empowering Progress in Digestive Medicine ResearchAdvances in Digestive Medicine is a premier scholarly journal dedicated to the evolving field of gastrointestinal health and diseases. Published by WILEY, this journal aims to disseminate high-quality research encompassing a wide range of topics related to digestive medicine, from foundational studies to innovative clinical applications. As a significant resource for researchers, professionals, and students alike, Advances in Digestive Medicine fosters a deeper understanding of digestive disorders, promoting collaboration and knowledge exchange within the scientific community. Although it offers subscription-based access, the journal ensures comprehensive coverage of groundbreaking studies that significantly impact clinical practice and patient care in the field. With an ISSN of 2351-9797 and an E-ISSN of 2351-9800, it stands as an essential platform for anyone involved in digestive health research.
GUT
Pioneering Research for Digestive Health ExcellenceGUT is a premier journal in the field of gastroenterology, published by the esteemed BMJ Publishing Group. With a rich history dating back to 1960 and an impressive convergence of research expected to continue through 2024, GUT has established itself as a cornerstone of academic discourse in the gastrointestinal sciences. The journal boasts a remarkable impact factor, positioning it in the Q1 category for gastroenterology with an outstanding rank of #3 out of 167 in its Scopus ranking, reflecting its 98th percentile status among peers. Although it does not currently offer open access options, GUT remains dedicated to disseminating high-quality research, reviews, and clinical studies that advance the understanding of digestive health. Published in the United Kingdom, GUT serves as an essential resource for researchers, clinicians, and students aiming to stay at the forefront of innovations and developments in the field.
DIGESTION
Advancing gastroenterology through rigorous research.DIGESTION is a prestigious journal dedicated to advancing the field of gastroenterology, published by KARGER, a renowned publisher based in Switzerland. With a rich history dating back to 1896, this journal has continuously evolved and serves as a vital platform for researchers, professionals, and students alike. DIGESTION is recognized for its scholarly contributions, holding an impressive rank of 23 out of 167 in the Scopus database, placing it within the top 14% of gastroenterology journals, as evidenced by its Q2 classification. The journal's commitment to high-quality research is reflected in its wide-ranging scope, addressing various aspects of digestive health, clinical practices, and innovative therapies. Though not an open-access journal, it provides comprehensive access options that ensure the dissemination of crucial research findings to the global community. As we move towards 2024, DIGESTION continues to facilitate dialogue and insights in gastroenterological research, making it an indispensable resource for those in the field.
Gastroenterologia y Hepatologia
Empowering healthcare professionals with high-quality research.Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.